Table 5.
Negative feedback received by LHDs from community partners (n = 44)
| Feedback | n | (% of LHDs) |
|---|---|---|
| Confusion regarding clinical guidance for antiviral use | 18 | (41) |
| Confusion regarding the use of public vs. private stockpile antivirals | 11 | (25) |
| Dissatisfaction regarding which patients should receive antivirals from public stockpile | 11 | (25) |
| Antiviral availability | 10 | (23)** |
| Administrative challenges associated with antivirals | 10 | (23) |
| Burdensome paperwork associated with tracking antiviral utilization | 4 | (9) |
| Difficulty determining whether local stockpiles had been depleted | 3 | (7) |
| Reported misuse of publicly purchased antivirals | 2 | (5) |
| Antiviral storage or security | 1 | (2) |
**Indicates statistically significant difference with respect to population size served by LHD (Fisher's exact test, p < .05)